Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
With a market cap of 217.71B, Novo Nordisk(NVO) trades at $49.30. The stock has a price-to-earnings ratio of 13.36 and currently yields dividends of 2.7%.
On 2025-11-11, Novo Nordisk(NVO) stock moved within a range of $46.53 to $49.43. With shares now at $49.30, the stock is trading +6.0% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 27.22M, compared to an average daily volume of 21.86M.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
NVO News
3 Buy-And-Forget Dividend Stocks With Snowballing Payouts Quick Read TSMC (TSM) manufactures chips for Nvidia and AMD and holds major pricing power over the te...
Prothena (PRTA) announced the publication of Phase 2 clinical trial data for coramitug for the treatment of ATTR amyloidosis with cardiomyopathy in the American...
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs. The market for GLP-1 drugs is already white-hot a...
Analyst ratings
61%
of 33 ratingsMore NVO News
After losing out to Pfizer for a weight-loss drug startup, Novo Nordisk will now have to count more heavily on its own research labs for new drugs, even as it’s...
BofA lowered the firm’s price target on Novo Nordisk (NVO) to DKK 315 from DKK 375 and keeps a Neutral rating on the shares. The firm, which assumes a reported...
Metsera (MTSR) stock toppled Monday after the buyout battle with Pfizer (PFE) and Novo Nordisk (NVO) ended. Pfizer will acquire the small obesity-focused biotec...
Here are some of the stocks making notable moves in Monday's premarket action: TreeHouse Foods shares are surging 19% after the food and beverage company agree...
Danish drug giant Novo Nordisk’s shares rose modestly during early trading on Monday. This came after reports that Novo Nordisk’s pursuit of obesity market deal...
Tom Ittle/Reuters Novo Nordisk NOVO.B 2.59 %increase; green up pointing triangle shares rose Monday after the Danish drugmaker withdrew from a bidding war with...
While Novo Nordisk (NVO) may have lost Metsera (MTSR) to Pfizer (PFE), CEO Mike Doustdar doesn’t plan to give up on dealmaking any time soon, Eric Pfanner, Aaro...